COVID-19: Keep up to date with the latest pharmaceutical and healthcare news as the pandemic evolves

Leading the fight

Oxfordshire has a unique life sciences ecosystem which has enabled it to mobilise rapidly and lead the international response to COVID-19, says Sebastian Johnson
A double-edged sword

Oli Hudson and Paul Midgley, of Wilmington Healthcare, explain how coronavirus has expedited some parts of the Long Term Plan while putting others in jeopardy
Chain reaction

As the NHS battles to suppress the coronavirus, communities across Britain have been adjusting to a new reality. Meanwhile, pharma has taken on the task of managing, sustaining and boosting its international supply chains. The industry is, so far, rising to the challenge, creating a new template and a revised plan for the future

News

View all

AZ ramps up supply capacity for COVID-19 vaccine

Agreements with CEPI and Gavi and the Serum Institute of India will bring vaccine to low and middle-income countries and beyond, the firm said

5th June 2020

The Lancet retracts study linking hydroxychloroquine with deaths

The study linked the drug with higher death rates in patients with COVID-19

5th June 2020

Lilly bags expanded EU approval for Taltz

Taltz has been granted an additional indication for the treatment of patients across the full axSpA spectrum

5th June 2020

PharmaTimes talks to...Professor Saad Shakir

Professor Shakir, director of the Drug Safety Research Unit, explains the cytokine storm, a major killer in patients with severe COVID-19 infection

4th June 2020

Biogen launches digital self-help tool to support mental health in MS

ACT MySelf, was developed by Biogen in collaboration with people living with MS, the MS Trust, a team of MS specialist nurses and an MS clinical psychologist

4th June 2020

Web Exclusives

View all

Engaging neurodivergent talent for pharma roles

Neurodivergent individuals are systematically overlooked in recruitment processes but are a talent pool that could be highly valuable to the pharma sector, says Marita Hazeldene

The coronavirus challenge

Brendan Shaw says COVID-19 has tested fragility and resilience in our health systems - and we have failed

Stepping up

Victoria Langdon says it's time for big pharma to step up…or risk losing out to big tech

Returning to productivity post COVID-19

Accenture's Brad Michel considers how life sciences companies can begin to re-open as we tentatively move to easing lockdown restrictions

Magazine

View more from the latest edition

The collapse in non-COVID care

While the NHS has focused on fighting coronavirus, care for non-COVID patients has dropped sharply. Will those patients come back?

Closing the distance

Remote treatment calls for a collaborative approach

Leading the fight

Oxfordshire has a unique life sciences ecosystem which has enabled it to mobilise rapidly and lead the international response to COVID-19, says Sebastian Johnson

Safety first

Andrew Rut on why drug safety should be top of mind during COVID-19 development

A secure connection?

The doctor will see you (online) now, but so could the fraudsters

In greener shoes

Is pharma ready for the effects of the climate crisis on global health?

Amplifying the ask of patient communities

Ben Osborn, Pfizer’s UK country manager, shares his thoughts on why the Patient Partnership Index and the values it celebrates matter more now than ever before....